Anges Inc Stock Performance
| AMGXF Stock | USD 0.36 0.00 0.00% |
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and AnGes are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days AnGes Inc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, AnGes is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 11.5 B | |
| Total Cashflows From Investing Activities | -154 M | |
| Free Cash Flow | -11.5 B |
AnGes |
AnGes Relative Risk vs. Return Landscape
If you would invest 36.00 in AnGes Inc on December 19, 2024 and sell it today you would earn a total of 0.00 from holding AnGes Inc or generate 0.0% return on investment over 90 days. AnGes Inc is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded otc stocks are less volatile than AnGes, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
AnGes Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AnGes' investment risk. Standard deviation is the most common way to measure market volatility of otc stocks, such as AnGes Inc, and traders can use it to determine the average amount a AnGes' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| AMGXF |
Based on monthly moving average AnGes is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AnGes by adding AnGes to a well-diversified portfolio.
AnGes Fundamentals Growth
AnGes OTC Stock prices reflect investors' perceptions of the future prospects and financial health of AnGes, and AnGes fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AnGes OTC Stock performance.
| Return On Equity | -0.43 | |||
| Return On Asset | -0.24 | |||
| Operating Margin | (243.51) % | |||
| Current Valuation | 78.35 M | |||
| Shares Outstanding | 156.07 M | |||
| Price To Book | 0.73 X | |||
| Price To Sales | 2.69 X | |||
| Revenue | 64.15 M | |||
| EBITDA | (13.21 B) | |||
| Cash And Equivalents | 13.21 B | |||
| Cash Per Share | 86.31 X | |||
| Book Value Per Share | 184.39 X | |||
| Cash Flow From Operations | (11.38 B) | |||
| Earnings Per Share | (0.65) X | |||
| Total Asset | 45.46 B | |||
About AnGes Performance
By analyzing AnGes' fundamental ratios, stakeholders can gain valuable insights into AnGes' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if AnGes has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if AnGes has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.Things to note about AnGes Inc performance evaluation
Checking the ongoing alerts about AnGes for important developments is a great way to find new opportunities for your next move. OTC Stock alerts and notifications screener for AnGes Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| AnGes Inc generated a negative expected return over the last 90 days | |
| AnGes Inc has some characteristics of a very speculative penny stock | |
| AnGes Inc has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 64.15 M. Net Loss for the year was (13.68 B) with loss before overhead, payroll, taxes, and interest of (26 M). | |
| AnGes Inc has accumulated about 13.21 B in cash with (11.38 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 86.31, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing AnGes' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether AnGes' stock is overvalued or undervalued compared to its peers.
- Examining AnGes' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating AnGes' management team can have a significant impact on its success or failure. Reviewing the track record and experience of AnGes' management team can help you assess the OTC Stock's leadership.
- Pay attention to analyst opinions and ratings of AnGes' otc stock. These opinions can provide insight into AnGes' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for AnGes OTC Stock analysis
When running AnGes' price analysis, check to measure AnGes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnGes is operating at the current time. Most of AnGes' value examination focuses on studying past and present price action to predict the probability of AnGes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnGes' price. Additionally, you may evaluate how the addition of AnGes to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |